In-Process Controls Explained

Pharmaceutical manufacturing depends on maintaining control while production is in progress.

Waiting until final product testing to identify problems may be too late to prevent batch rejection, investigation, or product loss.

In-Process Controls (IPCs) provide the operational checks that help manufacturers monitor process performance throughout production.

They form an important part of GMP process control as outlined in Pharmaceutical GMP Compliance by providing timely information about whether critical manufacturing parameters remain within established limits.

This article explains what IPCs are, why they matter, how they are selected, and how regulators evaluate their execution and documentation during inspections.

What Are In-Process Controls (IPCs)?

In-process controls are predefined checks, tests, or measurements performed during manufacturing to monitor whether a process remains within approved operating parameters. They provide objective evidence that critical process parameters continue to meet established requirements before manufacturing is complete.

They may include:

• weight variation checks

• tablet hardness testing

• blend uniformity testing

• pH measurements

• temperature and pressure monitoring

• fill volume checks

• moisture content testing

IPCs are not optional quality checks. They are part of the validated manufacturing process.

Although the specific IPCs vary by dosage form and manufacturing process, every IPC is intended to monitor a process characteristic that could affect product quality if it moves outside the expected operating range.

Examples of In-Process Controls

Manufacturing Activity	Example IPC
Granulation	Moisture content
Blending	Blend uniformity
Compression	Tablet weight and hardness
Filling	Fill volume
Sterile manufacturing	Environmental monitoring or filter integrity (where applicable)

Why In-Process Controls Matter

IPCs serve several critical functions:

• detect process drift early

• prevent batch failure

• reduce reliance on end-product testing

• maintain validated state

• support real-time quality assurance

The purpose of running IPCs is not simply to collect manufacturing data. IPCs allow organizations to identify process variation while corrective action is still possible.

By detecting problems before manufacturing is complete, IPCs reduce the likelihood of producing non-conforming product and provide evidence that validated process parameters remained under control.

IPCs vs Final Product Testing

It is important to distinguish between:

• In-process controls - monitoring during production

• Final product testing - verification after production

Final testing confirms compliance with specifications.
IPCs help ensure the process stays on track.

An overreliance on final testing suggests weak process control.

Modern GMP philosophy emphasizes building quality into the process rather than relying solely on end-product inspection.

How GMP In-Process Controls Are Defined

In-process controls should be based on:

• Critical Process Parameters (CPPs)

• Critical Quality Attributes (CQAs)

• risk assessments

• process validation data

Parameters selected for monitoring must have a scientific rationale.

For example:

• compression force may affect tablet hardness.

• mixing time may affect blend uniformity.

• drying temperature may influence moisture content.

IPCs should directly monitor variables linked to product quality risk.

Sampling Frequency and Strategy

IPCs must define:

• sampling frequency

• sampling size

• acceptable criteria

• escalation triggers

Sampling frequency is not fixed across all products or processes.

It is determined during process development and validation based on process understanding, variability, product risk, and historical manufacturing performance.

Sampling should be risk-based. Higher-risk processes may require more frequent checks. Automated continuous monitoring may replace manual sampling in certain systems.

For example:

• every batch

• every 15 minutes

• every 30 minutes

• beginning/middle/end of batch

• continuous monitoring

Documentation and Traceability

IPCs must be:

• clearly defined in batch records

• executed as written

• documented contemporaneously

• reviewed appropriately

IPC records become part of the Executed Batch Record and provide evidence that manufacturing remained within approved operating parameters.

Missing or inaccurate IPC documentation may affect batch review, investigation quality, and ultimately batch disposition.

Batch record design and execution are discussed in Master vs Executed Batch Records.

Out-of-Trend vs Out-of-Specification IPC Results

Not all IPC deviations are equal.

Organizations should distinguish between:

• Out-of-specification (OOS) results - exceeding defined limits

• Out-of-trend (OOT) results - showing drift within limits

OOT signals may indicate emerging process instability. Failure to investigate recurring OOT trends can result in later batch failures.

IPCs must feed into deviation management systems when appropriate.

Not every abnormal IPC result requires batch rejection. However, every unexpected result should be evaluated to determine whether it represents normal process variation, emerging process drift, or loss of process control.

Formal investigation requirements for OOS events are discussed in Out-of-Specification (OOS) Investigations.

When in-process controls indicate that parameters are outside acceptable limits, product may need to be managed as non-conforming, as addressed in Control of Non-Conforming Product.

Operator Role in IPC Execution

Operators play a critical role in:

• performing measurements

• interpreting results

• escalating concerns

• recording data accurately

Training effectiveness directly affects IPC reliability.

If operators cannot recognize abnormal results or fail to escalate concerns, IPCs lose preventive value.

Automation and Digital IPC Monitoring

Modern manufacturing environments may use:

• real-time sensors

• automated weight control systems

• statistical process control software

• Manufacturing Execution Systems (MES)

Automation can enhance detection sensitivity but requires:

• defined alarm limits

• clear response procedures

• audit trail review

• controlled data integrity practices

Digital IPC systems must remain aligned with validated process parameters.

Common Inspection Findings Related to IPCs

Regulators frequently observe:

• IPC parameters not aligned with validated ranges

• inconsistent sampling frequency

• missing documentation

• failure to investigate recurring trends

• poor linkage between IPC deviations and root cause analysis

Weak IPC programs often indicate superficial process understanding.

Inspectors assess whether IPCs are meaningful controls - not just procedural steps.

Operational Perspective

In-process controls are preventive safeguards embedded within the manufacturing process.

They demonstrate that the process remains under control between validation and final testing.

A mature IPC program:

• links parameters to risk

• defines justified sampling strategies

• escalates abnormal trends

• documents execution accurately

• integrates with deviation management

During inspections, IPC records help demonstrate that manufacturing processes remained under control throughout production rather than relying solely on final product testing to detect quality problems.

Explore more on GMP Compliance

Browse VerethiQ resources on GMP expectations, inspection readiness, facility controls, training, contamination control, batch release, and quality system execution.